scholarly journals Juvenile Primary Fibromyalgia Syndrome

2020 ◽  
Author(s):  
Keyword(s):  
Fibromyalgia Syndrome ◽  
Primary Fibromyalgia ◽  
Primary Fibromyalgia Syndrome

scholarly journals A review of biobehavioral research in juvenile primary fibromyalgia syndrome

2000 ◽  
Vol 13 (6) ◽  
pp. 388-397 ◽  
Author(s):  
Susmita Kashikar-Zuck ◽  
Thomas B. Graham ◽  
Michelle D. Huenefeld ◽  
Scott W. Powers
Keyword(s):  
Fibromyalgia Syndrome ◽  
Primary Fibromyalgia ◽  
Primary Fibromyalgia Syndrome

scholarly journals Actigraphy-Based Physical Activity Monitoring in Adolescents With Juvenile Primary Fibromyalgia Syndrome

2010 ◽  
Vol 11 (9) ◽  
pp. 885-893 ◽  
Author(s):  
Susmita Kashikar-Zuck ◽  
Stacy R. Flowers ◽  
Emily Verkamp ◽  
Tracy V. Ting ◽  
Anne M. Lynch-Jordan ◽  
...  
Keyword(s):  
Physical Activity ◽  
Fibromyalgia Syndrome ◽  
Activity Monitoring ◽  
Physical Activity Monitoring ◽  
Primary Fibromyalgia ◽  
Primary Fibromyalgia Syndrome

Primary Fibromyalgia Syndrome and 5-Hydroxy-L-Tryptophan: A 90-Day Open Study

1992 ◽  
Vol 20 (2) ◽  
pp. 182-189 ◽  
Author(s):  
P Sarzi Puttini ◽  
I Caruso
Keyword(s):  
Side Effects ◽  
Open Study ◽  
Fibromyalgia Syndrome ◽  
Laboratory Evaluation ◽  
Quality Of Sleep ◽  
Tender Points ◽  
Primary Fibromyalgia ◽  
Overall Evaluation ◽  
Primary Fibromyalgia Syndrome

The efficacy and tolerability of 5-hydroxy-L-tryptophan (5- HTP) were studied in an open 90-day study in 50 patients affected by primary fibromyalgia syndrome. When all the clinical variables studied throughout the trial (number of tender points, anxiety, pain intensity, quality of sleep, fatigue) were compared with baseline results, they all showed a significant improvement ( P< 0.001). The overall evaluation of the patient condition assessed by the patient and the investigator indicated a ‘good’ or ‘fair’ clinical improvement in nearly 50% of the patients during the treatment period. A total of 15 (30%) patients reported side-effects but only one patient was withdrawn from the treatment for this reason. No abnormality in the laboratory evaluation was observed. It is concluded that 5-HTP is effective in improving the symptoms of primary fibromyalgia syndrome and that it maintains its efficacy throughout the 90-day period of treatment.

5-HT3 receptor antagonists regulate autonomic cardiac dysfunction in primary fibromyalgia syndrome

2007 ◽  
Vol 27 (11) ◽  
pp. 1025-1030 ◽  
Author(s):  
Matthias F. Seidel ◽  
Gunter F. Weinreich ◽  
Thomas Stratz ◽  
Wolfgang Müller
Keyword(s):  
Cardiac Dysfunction ◽  
Fibromyalgia Syndrome ◽  
Receptor Antagonists ◽  
Primary Fibromyalgia ◽  
Primary Fibromyalgia Syndrome
Sign in / Sign up

Export Citation Format

Share Document